The Nasdaq Stock Market ended the session with Catalyst Pharmaceuticals rising 5.51% to $3.83 on Monday while the Nasdaq Stock Market rose 0.97% to $12,498.40.

Catalyst Pharmaceuticals today’s close was $3.83, 37.86% under its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 11.6% for the current quarter and 4.6% for the next. The company’s growth estimates for the ongoing quarter is 25% and a drop 10% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.

Catalyst Pharmaceuticals’s Stock Top and Bottom Yearly Value

Catalyst Pharmaceuticals’s stock is valued at $3.83 at 16:22 EST, way below its 52-week high of $5.28 and way higher than its 52-week low of $2.55.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s worth is way higher than its 50-day moving average of $3.37 and higher than its 200-day moving average of $3.79.

LEAVE A REPLY

Please enter your comment!
Please enter your name here